Company: KW
Filing Date: 2025-11-07
Form Type: 424B3
Source: 0001408100-25-000180
Chunk: 57

Company: Kennedy-Wilson Holdings, Inc.
Filing Date: 2025-11-07
Form: 424B3
Chunk 57
---
, |     | 2024 |             |     | 2025 | Nine Months Ended September 30, |     | 2024 |             |
|:---------------------------------------------------------------------------|:----|:-----|---------------------------------:|:----|:-----|------------:|:----|:-----|--------------------------------:|:----|:-----|------------:|
| Net loss attributable to Kennedy-Wilson Holdings, Inc. common shareholders |     | $    |                            -21.2 |     | $    |       -77.4 |     | $    |                           -68.4 |     | $    |      -109.6 |
| Weighted average shares outstanding for basic                              |     |      |                      137,901,697 |     |      | 137,413,758 |     |      |                     137,930,576 |     |      | 137,896,626 |
| Basic loss per basic share                                                 |     | $    |                            -0.15 |     | $    |       -0.56 |     | $    |                           -0.50 |     | $    |       -0.79 |
| Weighted average shares outstanding for diluted(1)                         |     |      |                      137,901,697 |     |      | 137,413,758 |     |      |                     137,930,576 |     |      | 137,896,626 |
| Diluted loss per diluted share                                             |     | $    |                            -0.15 |     | $    |       -0.56 |     | $    |                           -0.50 |     | $    |       -0.79 |

(1) For the three months ended September 30, 2025 and 2024, a total of 41,091,049 and 41,054,195 potentially dilutive securities, respectively, have not been included in the diluted weighted average shares as they are anti-dilutive. For the nine months ended September 30, 2025 and 2024, a total of 40,509,481 and 40,505,660 potentially dilutive securities, respectively, have not been included in the diluted weighted average shares as they are anti-dilutive.

#### NOTE 13—SEGMENT INFORMATION

#### Segment Presentation
The Company evaluates its reportable segments in accordance with the guidance of ASC Topic 280, Segment Reporting, which aligns with how